Lead Partner 

Crown Bioscience is a cutting-edge translational technology company providing drug discovery and preclinical development services in the areas of oncology, immunology, inflammation, cardiovascular, and metabolic disease. We bring clarity to drug discovery and enable clients around the world to deliver superior clinical candidates. Our premier translational platforms for cancer, inflammation, and metabolic disease help our clients accelerate their new drug development programs.


Workshop Partner 

Studylog’s Animal Study Workflow Software® is designed for biomedical animal research and provides features for the design, planning, execution, analysis, and reporting of animal studies in a standardized, highly efficient manner, while protecting data integrity. Reducing many labs’ study-related labor by half, Studylog automates and streamlines the entire animal study process, making it easier, faster and cheaper, so researchers have more time and resources to get their job done.


Workshop Partner 

At Nilogen, we’ve developed the most clinically-relevant model of patient tumor biology and paired it with the latest analytical techniques, bioinformatics tools, and artificial intelligence algorithms to help translational scientists make better decisions about their candidate therapies. With this service offering, we are already helping companies uncover therapeutic candidates with the highest likelihood of success in the clinic, increasing the potential for success and reducing overall development costs.


Expertise Partner 

The Jackson Laboratory is a leading provider of cancer mouse models and in vivo oncology services and a National Cancer Institute designated Cancer Center. Drawing on decades of research experience we provide capabilities around model selection, husbandry and customizable oncology studies to help clients and researchers evaluate novel anti-cancer therapies. Our diverse oncology study protocols range from traditional xenograft services to PDX cancer models and advanced humanized mouse models for immuno-oncology drug development.

Sans titre - 2 - fond blanc

Expertise Partner 

For the past 20 years, genOway has aimed to improve the predictability and reliability of preclinical data by designing models of high physiological relevancy to best meet researchers’ needs. With a catalog of humanized immune checkpoint mouse models, and mice featuring the human immune system, genOway possesses a broad set of tools to help decipher the mechanism of action as well as the efficacy and safety of drugs targeting the immune system. Additionally, genOway owns strong intellectual property rights, combining patents and licensing agreements, enabling the company to provide end users the necessary freedom to operate.

biocytogen logos

Program Partner 

Biocytogen is a global one-stop drug discovery solution provider with operations in the US and China. Empowered by its cutting-edge gene editing technologies and state-of-art animal facility, Biocytogen developed a seamlessly integrated platform for efficient antibody drug discovery. The technical teams in Biocytogen support a comprehensive portfolio of products and services, covering in vivo/in vitro preclinical services, humanized models for immuno-oncology and autoimmune diseases, fully human antibody (via RenMab™ Mouse), therapeutic antibody discovery and development services, CMC/CDMO, and regulatory affairs support. Biocytogen collaborates with more than 70% of top 50 pharmaceutical and numerous biotech start-up companies worldwide.


Program Partner 

GemPharmatech Co., Ltd. is a leading company in China to provide high-quality animal model resources and services for biomedical community as well as pharmaceutical companies. Based on more than 16 years’ practice in laboratory animals of the former entity, GemPharmatech has the vision and is striving to become one of the best one-stop service center for production, distribution, and phenotyping of gene-modified mouse models for partners all across the world.


Program Partner 

Imagen was founded by two ex-AstraZeneca cell-biologists, leaders in the field of high content screening who pioneered research in systems biology and applications in personalised medicine. Imagen’s vision of developing an accurate method of modelling cancer tumours in the lab culminated with the development of the predictRx platform. To date we’ve modelled over 150,000 patient treatments. Together with experienced industry entrepreneurs, Imagen has grown to become a global provider of services to the pharmaceutical drug development industry through the launch of the predictTx platform.


Program Partner 

INOVOTION is a Contract Research Laboratory implementing a unique approach to In vivo evaluation of anti-cancer drug discovery including Immuno-oncology. Our cutting-edge proprietary technology base on human xenograft in an immunocompetent model allows to select the best-in-class compounds. By eliminating low value molecules early, INOVOTION accelerates your drug discovery process and significantly reduces its costs. INOVOTION propose a complete set of assays dedicated to early In vivo EFFICACY and TOXICITY evaluation.

certis logo1

Spotlight Partner 

Certis Oncology Solutions is a life science technology company committed to realizing the promise of precision oncology. Our product is “Oncology Intelligence™”—highly predictive therapeutic response data derived from advanced biological models of cancer. Our proprietary platform informs individual treatment decisions and accelerates the development of new cancer therapies. We partner with therapeutics developers to help close the problematic translation gap between preclinical studies and clinical trials. Through more clinically relevant, well-characterized and annotated models, advanced imaging technology and thoughtfully designed studies, Certis brings greater certainty to go/no-go development decisions.


Spotlight Partner 

Labcorp Oncology is committed to advancing cancer care by pioneering scientific breakthroughs, powering better decisions through actionable data-driven patient insights and bringing healthcare within reach for all cancer patients throughout their continuum of care. With our comprehensive, specialized diagnostic services and our drug development capabilities, Labcorp is uniquely positioned to support you, from discovery through post-marketing and commercialization—using a biomarker-driven strategy throughout the entire process.



Spotlight Partner 

Kiyatec is a functional precision oncology company that accurately measures the response of each patient’s live cancer cells to aid in drug development and inform clinical treatment decisions. The company works in partnership with leading biopharmaceutical companies to unlock response dynamics for their pre-clinical investigational drug candidates across most solid tumor types. Kiyatec’s CLIA- certified labs offer clinical testing for high-grade glioma, and is developing assays for use in ovarian, breast, NSCLC, and rare tumors.


Spotlight Partner 

We are an innovative pre-clinical contract services, products & licensing company. Our mission is to use cutting-edge gene-editing technologies to accelerate pre-clinical research and drug development. Using our gene editing tools, Hera built the SRG™ platform, a double knockout Sprague-Dawley rat engineered for T-cell, B-cell, and NK cell deficiency. Our first SRG model is the SRG OncoRat®which  is uniquely suited for xenograft oncology studies given its excellent tumor take-rates and smooth transition from efficacy to safety.


Spotlight Partner 

Founded in 2007, is the world's leading and fastest-growing marketplace for outsourced scientific services and products. The marketplace saves time and money and provides access to innovation while maintaining compliance with an organization’s procurement policies. operates private marketplaces for most of the world’s major pharmaceutical companies, over 100 biotechs and the US National Institutes of Health (NIH). The marketplace features 3,900+ registered suppliers offering more than 4,000 research areas across multiple industries


Spotlight Partner 

We have developed novel technology that generates, collects, structures, and analyzes vast amounts of data and merged with the power of AI, we can advance precision medicine today, and in parallel, facilitate discovery, development and delivery of optimal therapeutics for tomorrow.

RBC Logo.  (PRNewsFoto/Reaction Biology Corporation)

Exhibition Partner 

Contract research organization with commitment to quality data and quality support. Let's Discover Together.